An adhesion
barrier is a medical implant which is used for healing coronary artery after
the cardiovascular surgeries. Adhesion barrier are made from oxidized
regenerated cellulose, expanded polyterafluorethylene, sodium hylauronate, and
carboxymethlcellulose. These barrier act as a physical films, gels, fabrics, or
other materials applied between coatings of tissues at the end of a surgery
before the slit site is closed. The formation of adhesion can cause
infertility, chronic pain, and bowel obstructions are some of the major risks
associated during the surgery. The abdominal surgery gives rise to adhesions in
large amounts compared to other surgeries.
According to
study, “Global
Adhesion Barrier Market 2019 by Manufacturers, Regions, Type and Application,
Forecast to 2024” some of the key companies operating in the global
adhesion barrier market are BaxterInternational Inc., Integra Lifesciences
Holdings Corp., Johnson & Johnson (J&J), Medtronic, Sanofi Group, C. R.
Bard, Becton dickinson and company, Getinge, Yishengtang, Haohai Biological,
Atrium Medical Corp., MAST Biosurgery, Singclean, Anika Therapeutics, Hangzhou
Singclean Medical Products Co., Ltd., FzioMed Inc. All the key players are
investing on research and development (R&D) for improving adhesion barriers
products producing better results.
Based on product,
the global adhesion barrier market is segmented into natural adhesion barriers
and synthetic adhesion barrier. The natural adhesion barriers include fibrin
and collagen & protein and thesynthetic adhesion barriers primarily include
regenerated cellulose, hyaluronic acid, polyethylene glycol and others.
SprayGel and SprayShield are most commonly used adhesion barriers. The use of
Polyethylene glycol based adhesion barrier is expected to register the fast
growth over the forecast period owing to properties of biocompatibility &
absorbability.
Based on the
formulation, market is segmented into gel, film (GynecareInterceed, Seprafilm
and Epifilm) or mesh and liquid (Adept and Bio-Gide Perio). The adhesion
barrier gels are composed of sodium carboxy methylcellulose and polyethylene
oxide, with the protective covering. The use of gels prevents the configuration
of post-surgical intrauterine adhesions, some of the gel used as the adhesion
barriers are Betamix, DYNAVISC, and Oxiplex/AP. The use of liquid form in
adhesion barriers are usually made of high molecular glucose polymers, for
instance Icodextrin, which prevents the internal tissue surfaces & organ
from adhering to each other during or post-surgery. Based on the application,
market is segmented into orthopedic surgeries, gynecological surgeries,
cardiovascular surgeries, abdominal general surgeries, urological surgeries,
neurological surgeries and others.
The global
adhesion barrier market is primarily driven by the rise in geriatric population
followed by the increase in prevalence of chronic diseases, and rise in
sports-related injuries. However, reluctance towards the use of adhesion
barriers among surgeons is one of the biggest factors impacting the growth of
market. Moreover, major growth of the market is expected to arise from untapped
emerging markets.
Increase over the
health concerns have made patients attentive for the use of better healthcare
options with the use of advanced care techniques are expected to enhance the
global adhesion market over the forecast period. North American region is
expected to witness considerable growth of adhesion barrier market owing to
rise in demand of technologically advanced healthcare facilities. The
Asia-Pacific region is also expected to witness substantial growth owing to increase
in population. In 2019, the value of global adhesion barrier market reached at
US $820 million and is projected to reach at US $1,310 million, by 2024.
To know more,
click on the link below:-
Related Reports:-
Contact Us:-
Ken Research
Ankur Gupta, Head
Marketing & Communications
Sales@kenresearch.com
+91-9015378249
No comments:
Post a Comment